Cleared Special

K221986 - XO Score LP Percutaneous Transluminal Angioplasty Scoring Catheter, XO Score LP Catheter (FDA 510(k) Clearance)

Oct 2022
Decision
104d
Days
Class 2
Risk

K221986 is an FDA 510(k) clearance for the XO Score LP Percutaneous Transluminal Angioplasty Scoring Catheter, XO Score LP Catheter. This device is classified as a Catheter, Percutaneous, Cutting/scoring (Class II - Special Controls, product code PNO).

Submitted by Transit Scientific, LLC (Salt Lake City, US). The FDA issued a Cleared decision on October 18, 2022, 104 days after receiving the submission on July 6, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250. To Reduce Vascular Stenosis By Dilatation And Apposition Of The Cutting/scoring Surfaces To The Stenotic Material.

Submission Details

510(k) Number K221986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2022
Decision Date October 18, 2022
Days to Decision 104 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PNO - Catheter, Percutaneous, Cutting/scoring
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Reduce Vascular Stenosis By Dilatation And Apposition Of The Cutting/scoring Surfaces To The Stenotic Material